Literature DB >> 2026028

Oxygen transport in cardiogenic and septic shock.

J D Edwards1.   

Abstract

OBJECTIVE: To review clinical studies of oxygen transport in cardiogenic and septic shock.
DESIGN: Descriptive and prospective studies.
SETTING: University hospital multi disciplinary ICU. PATIENTS: Critically ill cardiogenic and septic shock patients greater than 18 and less than 80 yrs of age.
INTERVENTIONS: The responses to volume loading with colloid or crystalloid and infusion of catecholamines are documented with baseline hemodynamic and oxygen transport measurements before and after administration of catecholamines.
MEASUREMENTS AND MAIN RESULTS: Nineteen patients in cardiogenic shock were studied. In three patients, invasive systemic mean arterial pressure was greater than 80 mm Hg and cardiac index was greater than 2.0 L/min.m2. In all patients, there were increases in oxygen extraction ratio that averaged 48 +/- 18 (SD) %. However, in 30 septic shock patients, extraction ratio was 24 +/- 2%. In both groups, the response to therapy was an increase in mixed venous oxygen saturation from 54 +/- 16% to 69 +/- 8% in cardiogenic patients (p less than .001) and from 75 +/- 2% to 80 +/- 1% in septic shock (p less than .01).
CONCLUSIONS: There are widely differing oxygen transport patterns in cardiogenic and septic shock that may have implications for therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026028     DOI: 10.1097/00003246-199105000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Near-infrared spectroscopy for evaluation of global and skeletal muscle tissue oxygenation.

Authors:  Hugon Možina; Matej Podbegar
Journal:  World J Cardiol       Date:  2011-12-26

2.  Changes of oxygen transport variables and serum lactate during open-chest cardiac massage in dogs.

Authors:  Michihiko Fukui; Tetsuo Hatanaka; Masami Yoshioka; Tsutomu Yan; Nobuaki Shime; Yoshifumi Tanaka
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

3.  Inferior Vena Cava Oxygen Saturation during the First Three Postnatal Days in Preterm Newborns with and without Patent Ductus Arteriosus.

Authors:  Ece Yapakçı; Ayşe Ecevit; Deniz Anuk Ince; Mahmut Gökdemir; M Agah Tekindal; Hande Gülcan; Aylin Tarcan
Journal:  Balkan Med J       Date:  2014-09-01       Impact factor: 2.021

Review 4.  Critical care in the emergency department: severe sepsis and septic shock.

Authors:  P A Nee
Journal:  Emerg Med J       Date:  2006-09       Impact factor: 2.740

5.  The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat heart and lung during endotoxin shock.

Authors:  N Tanaka; T Kita; K Kasai; T Nagano
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill.

Authors:  Konrad Reinhart; Hans-Jörg Kuhn; Christiane Hartog; Donald L Bredle
Journal:  Intensive Care Med       Date:  2004-06-09       Impact factor: 17.440

7.  Dynamics of skin blood flow in human sepsis.

Authors:  J D Young; E M Cameron
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

Review 8.  The pulmonary physician and critical care. 6. Oxygen transport: the relation between oxygen delivery and consumption.

Authors:  R M Leach; D F Treacher
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

9.  No agreement of mixed venous and central venous saturation in sepsis, independent of sepsis origin.

Authors:  Paul A van Beest; Jan van Ingen; E Christiaan Boerma; Nicole D Holman; Henk Groen; Matty Koopmans; Peter E Spronk; Michael A Kuiper
Journal:  Crit Care       Date:  2010-11-29       Impact factor: 9.097

10.  Skeletal muscle oxygen saturation does not estimate mixed venous oxygen saturation in patients with severe left heart failure and additional severe sepsis or septic shock.

Authors:  Matej Podbregar; Hugon Mozina
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.